Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thioacetamide hepatocarcinogenesis.

F F Becker

    Journal of the National Cancer Institute
    |September 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Thioacetamide (TAA) is a hepatocarcinogen that induces liver cancer in rats. Diet composition, specifically riboflavin and thyroid supplements, influences the type of liver tumors, including primary hepatocarcinomas and cholangiocarcinomas, that develop.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PROGRAMMABLE DIELECTROPHORETIC μTAS SAMPLE HANDLING.

    Micro total analysis systems : proceedings of the ... [Mu] TAS International Conference on Miniaturized Chemical and Biochemical Analysis Systems. [Mu] TAS (Conference)·2013
    Same author

    Presentation of the rous-whipple award to morris j. Karnovsky-1981.

    The American journal of pathology·2009
    Same author

    Presentation of the rous-whipple award to emmanuel farber: 1982.

    The American journal of pathology·2009
    Same author

    Synthesis, electrophilic substitution and structure-activity relationship studies of polycyclic aromatic compounds towards the development of anticancer agents.

    Current medicinal chemistry·2001
    Same author

    Polycyclic aromatic compounds as anticancer agents: structure-activity relationships of chrysene and pyrene derivatives.

    Bioorganic & medicinal chemistry·2001
    Same author

    Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of dibenzofluorene derivatives.

    Bioorganic & medicinal chemistry·2000
    Same journal

    Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

    Journal of the National Cancer Institute·2026
    Same journal

    Beyond R2: Assessing quality of trial level surrogate endpoints in colorectal cancer.

    Journal of the National Cancer Institute·2026
    Same journal

    A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

    Journal of the National Cancer Institute·2026
    Same journal

    Response to Yu, Wang and Ge.

    Journal of the National Cancer Institute·2026
    Same journal

    Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

    Journal of the National Cancer Institute·2026
    Same journal

    Welcome reduction of US cervical cancer rates despite state differences.

    Journal of the National Cancer Institute·2026
    See all related articles

    Area of Science:

    • Toxicology
    • Hepatocarcinogenesis
    • Animal Models

    Background:

    • Thioacetamide (TAA) is a known chemical inducer of liver injury and cancer.
    • Understanding the factors influencing TAA-induced hepatocarcinogenesis is crucial for cancer research.

    Purpose of the Study:

    • To investigate the hepatocarcinogenic potential of thioacetamide (TAA) in male ACI rats over a 1-year period.
    • To evaluate the influence of dietary modifications, specifically riboflavin and thyroid supplementation, on TAA-induced liver lesions and tumor development.

    Main Methods:

    • Inbred male ACI rats were administered TAA (0.035% in diet) for 1 year.
    • Four experimental groups were established: TAA alone, TAA with low riboflavin, TAA with thyroid supplement, and TAA with both supplements.
    • Histopathological examination was performed to assess liver lesions, including cirrhosis, neoplastic nodules, and cholangiofibromas.

    Related Experiment Videos

    Main Results:

    • All TAA-administered groups developed varying degrees of cirrhosis, neoplastic nodules, and cholangiofibromas.
    • Group IV (TAA + riboflavin + thyroid) exhibited the most advanced lesions.
    • Primary hepatocarcinomas (PHC) were induced by TAA alone, TAA with thyroid, and TAA with both supplements, with the highest incidence in Group IV.
    • Primary cholangiocarcinomas (PCC) were exclusively induced in Group II (TAA with low riboflavin).
    • Transplantation studies confirmed the successful engraftment of both PHC and PCC.

    Conclusions:

    • Thioacetamide (TAA) is a potent hepatocarcinogen capable of inducing both primary hepatocarcinomas (PHC) and primary cholangiocarcinomas (PCC) in rats.
    • Dietary components, such as riboflavin and thyroid hormones, significantly modulate the type and progression of TAA-induced liver tumors.
    • The study highlights the importance of dietary context in chemical carcinogenesis research.